{"id":"W3165476304","doi":"10.1136/annrheumdis-2021-eular.850","title":"POS0446 FILGOTINIB-TREATED RHEUMATOID ARTHRITIS PATIENTS WITH HIGH BASELINE NEUTROPHIL-TO-LYMPHOCYTE RATIO SHOW BETTER CLINICAL RESPONSE RATES AND PATIENT-REPORTED OUTCOMES","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Canadian Arthritis Network; Vrije Universiteit Amsterdam; Canadian Institutes of Health Research; University of Leeds; Ontario Ministry of Health and Long-Term Care; Bristol-Myers Squibb; Universitätsspital Basel; Università degli Studi di Milano; Sanofi; Université Paris-Saclay; Pfizer","keywords":"Medicine; Internal medicine; Rheumatoid arthritis; Population; Post-hoc analysis; Rituximab; Methotrexate; Adalimumab; Neutrophil to lymphocyte ratio; Clinical trial; TNF inhibitor; Lymphocyte; Immunology; Gastroenterology; Lymphoma","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005649927,0.0002850183,0.0006793477,0.0002249654,0.000213358,0.0005265228,0.0001410155,0.0003610468,0.004316239],"category_scores_gemma":[0.001151533,0.0000729269,0.0005086813,0.0003196567,0.0001311912,0.0003349175,0.0001754785,0.0005608505,0.000882984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002210302,"about_ca_system_score_gemma":0.0002090875,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005186178,"about_ca_topic_score_gemma":0.001051035,"domain_scores_codex":[0.9996182,0.00009321659,0.00004853876,0.00006806499,0.00007337659,0.00009865805],"domain_scores_gemma":[0.9991601,0.0001902811,0.0003861169,0.000041078,0.00009581914,0.0001266487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02564766,0.001019216,0.688325,0.0008061163,0.001297667,0.0005983266,0.0001573018,0.0008278187,0.02573476,0.0002983323,0.006684992,0.2486028],"study_design_scores_gemma":[0.0008351347,0.005439573,0.9824226,0.00007210913,0.0006179428,0.001792509,0.0001418448,0.0008192661,0.002031656,0.0002730341,0.005523618,0.00003075779],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873042,0.004557061,0.0002754818,0.0003412353,0.0001211309,0.00003510528,0.0009708896,0.00005801891,0.006337015],"genre_scores_gemma":[0.9973134,0.0004720547,0.0001457529,0.0002770132,0.00008514493,0.00001897544,0.000935036,0.000006400051,0.000746187],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004316239,"threshold_uncertainty_score":0.01443928,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02917616228633254,"score_gpt":0.3242427068119283,"score_spread":0.2950665445255958,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}